PubRank

Donald I Abrams

Author PubWeight™ 50.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008 5.30
2 Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus. N Engl J Med 2003 4.27
3 HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009 3.13
4 Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy. AIDS 2003 2.66
5 Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol 2009 2.35
6 It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park) 2013 2.07
7 HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011 2.02
8 The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. Control Clin Trials 2002 1.73
9 Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 2007 1.72
10 Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases. J Acquir Immune Defic Syndr 2008 1.49
11 Contrasts, conflicts, and change: A case in cultural oncology. J Support Oncol 2006 1.40
12 AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol 2007 1.25
13 Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 2012 1.07
14 Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study. BMC Infect Dis 2013 0.98
15 HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS 2011 0.98
16 Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma. Clin Cancer Res 2012 0.96
17 Medicinal cannabis: rational guidelines for dosing. IDrugs 2004 0.94
18 Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr 2014 0.94
19 Disadvantages of structured treatment interruption persist in patients with multidrug-resistant HIV-1: final results of the CPCRA 064 study. J Acquir Immune Defic Syndr 2006 0.91
20 Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2. Clin Infect Dis 2003 0.90
21 Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients. J Clin Pharmacol 2002 0.89
22 Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS 2009 0.88
23 Hematopoietic cell transplant and use of massage for improved symptom management: results from a pilot randomized control trial. Evid Based Complement Alternat Med 2012 0.86
24 The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS 2002 0.85
25 The efficacy of distant healing for human immunodeficiency virus--results of a randomized trial. Altern Ther Health Med 2006 0.83
26 Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther 2011 0.83
27 The BraveNet prospective observational study on integrative medicine treatment approaches for pain. BMC Complement Altern Med 2013 0.82
28 Integrating dietary supplements into cancer care. Integr Cancer Ther 2013 0.81
29 Massage for children undergoing hematopoietic cell transplantation: a qualitative report. Evid Based Complement Alternat Med 2012 0.80
30 Patients seek integrative medicine for preventive approach to optimize health. Explore (NY) 2012 0.80
31 Non-AIDS-Defining Malignancies in the HIV-Infected Population. Curr Infect Dis Rep 2014 0.78
32 Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected Men. AIDS Res Treat 2012 0.77
33 Cannabis in palliative medicine: improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care 2011 0.77
34 Can clinicians now assure their breast cancer patients that soyfoods are safe? Womens Health (Lond Engl) 2010 0.76
35 Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival. AIDS 2015 0.75
36 New insights into the role of HIV infection on cancer risk. Lancet Oncol 2009 0.75
37 What's the alternative? N Engl J Med 2012 0.75
38 Not soy simple. J Soc Integr Oncol 2010 0.75
39 Using Medical Cannabis in an Oncology Practice. Oncology (Williston Park) 2016 0.75
40 Nausea at the end of adjuvant cancer treatment in relation to exercise during treatment in patients with breast cancer. Oncol Nurs Forum 2008 0.75